Found: 23
Select item for more details and to access through your institution.
Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 14, p. 1036, doi. 10.1093/jnci/djt146
- By:
- Publication type:
- Article
Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 17, p. 1262, doi. 10.1093/jnci/dji250
- By:
- Publication type:
- Article
A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Drug-induced Thrombotic Microangiopathy with Concurrent Proteasome Inhibitor Use in the Treatment of Multiple Myeloma: A Case Series and Review of the Literature.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial.
- Published in:
- Current Oncology, 2021, v. 28, n. 2, p. 1256, doi. 10.3390/curroncol28020119
- By:
- Publication type:
- Article
A Canadian Prospective Study of Linkage of Randomized Clinical Trial to Cancer and Mortality Registry Data.
- Published in:
- Current Oncology, 2021, v. 28, n. 2, p. 1153, doi. 10.3390/curroncol28020111
- By:
- Publication type:
- Article
Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 169, n. 3, p. 537, doi. 10.1007/s10549-018-4713-2
- By:
- Publication type:
- Article
Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor-Treated Patients: CCTG MA.27.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Effect of Metformin vs Placebo on Weight and Metabolic Factors in NCIC CTG MA.32.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 3, p. 1, doi. 10.1093/jnci/djv006
- By:
- Publication type:
- Article
Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Capnocytophaga canimorsus, a potential emerging microorganism in splenectomized patients.
- Published in:
- British Journal of Haematology, 2000, v. 109, n. 4, p. 679, doi. 10.1046/j.1365-2141.2000.02222.x
- By:
- Publication type:
- Article
Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial.
- Published in:
- Oncologist, 2023, v. 28, n. 9, p. 799, doi. 10.1093/oncolo/oyad128
- By:
- Publication type:
- Article
Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer.
- Published in:
- Clinical Epigenetics, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13148-019-0750-x
- By:
- Publication type:
- Article
Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00275-z
- By:
- Publication type:
- Article
Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo.
- Published in:
- JNCI Cancer Spectrum, 2021, v. 5, n. 5, p. 1, doi. 10.1093/jncics/pkab066
- By:
- Publication type:
- Article
Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trial.
- Published in:
- Breast Cancer Research, 2014, v. 16, n. 1, p. 1, doi. 10.1186/bcr3600
- By:
- Publication type:
- Article
Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC Cohort.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Interaction Between SNP Genotype and Efficacy of Anastrozole and Exemestane in Early‐Stage Breast Cancer.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 4, p. 1038, doi. 10.1002/cpt.2311
- By:
- Publication type:
- Article
Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27.
- Published in:
- 2018
- By:
- Publication type:
- journal article